CTXR Citius Pharmaceuticals Inc
Company Analysis
Latest News
🟢 Citius Pharmaceuticals is trading 11% up with no clear company-specific catalyst identified
Citius Pharmaceuticals is trading up 10.54% at $0.41 on October 23, 2026; no clear company-specific catalyst was identified in available search results. - The...
🟢 Citius Pharmaceuticals is trading 5% up today
Citius Pharmaceuticals is trading at $0.39, up 5.12%, with no clear catalyst identified for the October 23 move. - The latest located company release was an...
🔴 Citius Pharmaceuticals is trading 6.42% down today with no fresh company-specific announcement identified
Citius Pharmaceuticals is trading at $0.37, down 6.42%, with no fresh company-specific announcement identified to explain the October 22 move. - The latest...
🟢 Citius Pharmaceuticals is trading 6% up in pre-market; no clear catalyst identified
Citius Pharmaceuticals is trading 5.94% up at $0.42 in pre-market on October 22, 2026, with no clear catalyst identified. - No fresh company-specific...
🔴 Citius Pharmaceuticals is trading 7.5% down as the catalyst remains unclear
Citius Pharmaceuticals is trading at $0.43, down 7.48%; the reason for the decline remains unclear. - No fresh company-specific announcement explaining the...
🟢 Citius Pharmaceuticals is trading 5% up in pre-market
Citius Pharmaceuticals is trading at $0.49, up +5.42%, with no verified company-specific news explaining the pre-market rise. - The latest company...
🟢 Citius Pharmaceuticals is trading 5% up in pre-market
Citius Pharmaceuticals is trading 5.04% higher at $0.50 in pre-market, with no clear company-specific catalyst identified for the move. - The latest company...
🔴 Citius Pharmaceuticals is trading 6.6% down with no clear company-specific catalyst
Citius Pharmaceuticals is trading at $0.46, down -6.64%, with no clear company-specific announcement explaining the decline. - The latest company news found...
🟢 Citius Pharmaceuticals is trading 5% up
Citius Pharmaceuticals is trading at $0.51, up 5.06%, with no clear new company-specific announcement found to explain the October 7 move. - Healthcare was up...
🟢 Citius Pharmaceuticals is trading 6.1% up in pre-market
Citius Pharmaceuticals is trading 6.1% higher at $0.51 in pre-market on October 7, 2026; no clear company-specific catalyst was identified. - Shares fell...
🔴 Citius Pharmaceuticals is trading 5.4% down today — immediate cause remains unclear
Citius Pharmaceuticals is trading 5.4% lower at $0.49, with no clear company-specific announcement explaining its October 6, 2026 decline. - Latest company...
🟢 Citius Pharmaceuticals is trading 5% up with no clear catalyst identified
Citius Pharmaceuticals is trading 5.08% up at $0.56, with no clear company-specific catalyst identified for the October 1 move. - The prior after-hours...
🟢 Citius Pharmaceuticals is trading 7.3% up in after-hours trading; no clear catalyst identified
Citius Pharmaceuticals is trading 7.3% up at $0.57 in after-hours, with no clear company-specific announcement identified to explain the move. - It closed the...
🔴 Citius Pharmaceuticals is trading 5% down in pre-market — no company-specific explanation identified
Citius Pharmaceuticals is trading at $0.52, down 5.21%, with no fresh company-specific announcement identified to explain the September 29 pre-market...
🔴 Citius Pharmaceuticals is trading 8% down today with no fresh company-specific news identified
Citius Pharmaceuticals is trading at $0.53, down 7.74%, with no fresh company-specific announcement identified to explain the decline. - On September 28,...
🟢 Citius Pharmaceuticals is trading 6.93% up today amid stronger overall market sentiment
Citius Pharmaceuticals is trading 6.93% up at $0.60, with no clear company-specific announcement identified for September 17, 2026; the move appears aligned...
🟢 Citius Pharmaceuticals is trading 8.91% up in pre-market — no clear company-specific catalyst identified
Citius Pharmaceuticals is trading 8.91% up at $0.61 after no clearly disclosed company-specific catalyst was identified for September 16, 2026. - Management...
🟢 Citius Pharmaceuticals is trading 5% up today after announcing two upcoming investor conference presentations
Citius Pharmaceuticals is trading 5.25% up at $0.61 after announcing on September 3, 2026, that CEO Leonard Mazur will present at two upcoming investor...
🔴 Citius Pharmaceuticals is trading 5% down today
Citius Pharmaceuticals is trading 5.09% down now at $0.60, amid modestly lower broader markets, cautious Federal Reserve messaging, and weaker risk...
🟢 Citius Pharmaceuticals is trading 12% up today amid broader market gains
Citius Pharmaceuticals is trading at $0.65, up +11.97%, alongside stronger market sentiment. - The Nasdaq is up 1.40% and the S&P 500 is up 0.63%. - No fresh...